174 related articles for article (PubMed ID: 25119002)
21. Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.
Song MK; Chung JS; Joo YD; Lee SM; Oh SY; Shin DH; Yun EY; Kim SG; Seol YM; Shin HJ; Choi YJ; Cho GJ
J Neurooncol; 2011 Sep; 104(3):825-31. PubMed ID: 21380743
[TBL] [Abstract][Full Text] [Related]
22. Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.
Jahnke K; Korfel A; Komm J; Bechrakis NE; Stein H; Thiel E; Coupland SE
Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):663-9. PubMed ID: 16228920
[TBL] [Abstract][Full Text] [Related]
23. Primary central nervous system lymphoma--a hospital based study of incidence and clinicopathological features from India (1980-2003).
Sarkar C; Sharma MC; Deb P; Singh R; Santosh V; Shankar SK
J Neurooncol; 2005 Jan; 71(2):199-204. PubMed ID: 15690139
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme.
Cerqua R; Balestrini S; Perozzi C; Cameriere V; Renzi S; Lagalla G; Mancini G; Montanari M; Leoni P; Scerrati M; Iacoangeli M; Silvestrini M; Luzzi S; Provinciali L
Neurol Sci; 2016 Jan; 37(1):23-29. PubMed ID: 26233232
[TBL] [Abstract][Full Text] [Related]
25. Role of vitreous cytology in the diagnosis of primary central nervous system lymphoma: A report of an unusual presentation.
Tom JP; Gupta P; Radotra BD; Gupta N; Takkar A; Singh S; Gupta V
Diagn Cytopathol; 2023 Aug; 51(8):E232-E238. PubMed ID: 37148480
[TBL] [Abstract][Full Text] [Related]
26. A study of primary central nervous system lymphoma in northern India.
Powari M; Radotra B; Das A; Banerjee AK
Surg Neurol; 2002 Feb; 57(2):113-6. PubMed ID: 11904205
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Factors and Survival in Primary Central Nervous System Lymphoma: A Population-Based Study.
Shan Y; Hu Y
Dis Markers; 2018; 2018():7860494. PubMed ID: 30050595
[TBL] [Abstract][Full Text] [Related]
28. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
[TBL] [Abstract][Full Text] [Related]
29. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
30. Central nervous system lymphoma: patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield.
Manoj N; Arivazhagan A; Mahadevan A; Bhat DI; Arvinda HR; Devi BI; Sampath S; Chandramouli BA
Neurol India; 2014; 62(1):19-25. PubMed ID: 24608449
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hatzl S; Posch F; Deutsch A; Beham-Schmid C; Stöger H; Greinix H; Pichler M; Neumeister P; Prochazka KT
Hematol Oncol; 2020 Aug; 38(3):277-283. PubMed ID: 32101329
[TBL] [Abstract][Full Text] [Related]
32. Optic Nerve Infiltration in Primary Central Nervous System Lymphoma.
Ahle G; Touitou V; Cassoux N; Bouyon M; Humbrecht C; Oesterlé H; Baraniskin A; Soussain C; Nguyen-Them L; Gaultier C; Hoang-Xuan K; Houillier C
JAMA Neurol; 2017 Nov; 74(11):1368-1373. PubMed ID: 28973119
[TBL] [Abstract][Full Text] [Related]
33. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.
Hoffman PM; McKelvie P; Hall AJ; Stawell RJ; Santamaria JD
Eye (Lond); 2003 May; 17(4):513-21. PubMed ID: 12802353
[TBL] [Abstract][Full Text] [Related]
34. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
35. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
36. The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.
Hottenrott T; Schorb E; Fritsch K; Dersch R; Berger B; Huzly D; Rauer S; Tebartz van Elst L; Endres D; Stich O
J Neurol; 2018 May; 265(5):1106-1114. PubMed ID: 29511863
[TBL] [Abstract][Full Text] [Related]
37. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
[TBL] [Abstract][Full Text] [Related]
38. Late relapse in primary central nervous system lymphoma: clonal persistence.
Nayak L; Hedvat C; Rosenblum MK; Abrey LE; DeAngelis LM
Neuro Oncol; 2011 May; 13(5):525-9. PubMed ID: 21372070
[TBL] [Abstract][Full Text] [Related]
39. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.
Haldorsen IS; Kråkenes J; Krossnes BK; Mella O; Espeland A
AJNR Am J Neuroradiol; 2009 Apr; 30(4):744-51. PubMed ID: 19164442
[TBL] [Abstract][Full Text] [Related]
40. Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.
Shin DW; Kim JH; Kim YH; Cho YH; Hong SH
J Neurooncol; 2020 Apr; 147(2):339-349. PubMed ID: 32221784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]